ARCHIVES

NIH Director: NCI’s Special Authorities “More Of A Negative Than A Positive”

This article is from The Cancer Letter archive.

Vol. 36 No. 22 | June 11, 2010

Download PDF Visit The Full Archive

Related Articles

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

DCE Advisors approver New Grant Programs In Ovarian Cancer, Biostatistics, Biotech Transfer; Support Services Recompetitions

June 19, 1992

In Brief: Deadline June 1 For New ACS Prevention Awards; Money Available To Fund Five More

April 11, 1980

Bypass Budget for FY 1989 to Ask $2 Billion For NCI, With Projection To $3 Billion by 1993

May 29, 1987

Drug Reimbursement: Senate Bill Worse For Oncologists

July 11, 1997

Cancer Control Program Guidelines Developed For Payment Of Patient Costs

December 21, 1973